{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:43:35Z","timestamp":1791996215564,"version":"4.4.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Understanding the different pharmacodynamic responses to narcotics in patients with or without obesity is particularly important for the safety of gastroscopy sedation. This study aimed to determine the median effective dose (ED50) of ciprofol combined with low-dose sufentanil to inhibit the response to gastroscope insertion in obese or nonobese patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 27 obese patients (BMI 30\u201340\u00a0kg\/m2) and 25 nonobese patients (BMI 18\u201325\u00a0kg\/m2), aged between 18 and 65\u00a0years, with ASA physical status of 1\u20132, were included in this study. All patients underwent painless gastroscopy and received intravenous sufentanil at a dose of 0.1\u00a0\u03bcg\/kg, followed by ciprofol administration. The initial dose of ciprofol for the first patient in both groups was 0.4\u00a0mg\/kg, the subsequent dose was determined by the response of the previous patient to gastroscope insertion (cough, choking, body movement, etc.) using Dixon\u2019s up-and-down method. The dose was increased or decreased by 0.05\u00a0mg\/kg depending on the observed responses. Data collection continued until 7 crossover points were obtained. Probit regression and bootstrapping methods were employed to calculate the median effective dose (ED50) and 95% confidence intervals (CIs). The ED50 values were then compared between the obese and nonobese patient groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The ED50 of ciprofol combined with sufentanil inhibiting response to gastroscope insertion in patients with obesity was 0.186\u00a0mg\/kg with 95% CI of 0.153\u223c0.209\u00a0mg\/kg, was significantly lower than patients with nonobese was 0.237\u00a0mg\/kg with 95% CI of 0.206\u223c0.253\u00a0mg\/kg (p &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The ED50 values of ciprofol combined with sufentanil inhibiting response to gastroscope insertion in patients with obesity was lower than in patients with normal weight.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.chictr.org.cn\/bin\/project\/edit?pid=202873<\/jats:ext-link>, identifier ChiCTR2300074216.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1521715","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T09:52:07Z","timestamp":1739872327000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["The median effective dose of ciprofol combined with a low-dose sufentanil for gastroscopy in obese or nonobese patients: a dose-finding study using Dixon\u2019s up-and-down method"],"prefix":"10.3389","volume":"16","author":[{"given":"Jie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/164_2021_558","article-title":"Obesity and obstructive sleep apnea","volume":"274","author":"Bonsignore","year":"2022","journal-title":"Handb. Exp. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"902065","DOI":"10.3389\/fphar.2022.902065","article-title":"The efficacy and safety of remimazolam tosilate versus dexmedetomidine in outpatients undergoing flexible bronchoscopy: a prospective, randomized, blind, non-inferiority trial","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/bja\/aeq195","article-title":"Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model","volume":"105","author":"Cort\u00ednez","year":"2010","journal-title":"Br. J. Anaesth."},{"key":"B34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0149-7634(05)80090-9","article-title":"Staircase bioassay: the up-and-down method","volume":"15","author":"Dixon","year":"1991","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1124\/dmd.116.071605","article-title":"Morbid obesity alters both pharmacokinetics and pharmacodynamics of propofol: dosing recommendation for anesthesia induction","volume":"44","author":"Dong","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"B5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacc.2013.05.045","article-title":"Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome","volume":"62","author":"Drager","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/19490976.2018.1465157","article-title":"The human gut microbiota: metabolism and perspective in obesity","volume":"9","author":"Gomes","year":"2018","journal-title":"Gut Microbes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e4697","DOI":"10.1097\/GOX.0000000000004697","article-title":"Obesity and complications in mammoplasty: a retrospective review in an obese patient population","volume":"10","author":"Hinson","year":"2022","journal-title":"Plastic Reconstr. Surg. - Glob. Open"},{"key":"B8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.sleep.2022.04.006","article-title":"Obstructive sleep apnea, intermittent hypoxia and non-alcoholic fatty liver disease","volume":"95","author":"Ji","year":"2022","journal-title":"Sleep. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/bcpt.13761","article-title":"Comparison of ciprofol (HSK3486) versus propofol for the induction of deep sedation during gastroscopy and colonoscopy procedures: a multi\u2010centre, non\u2010inferiority, randomized, controlled phase 3 clinical trial","volume":"131","author":"Li","year":"2022","journal-title":"Basic Clin. Pharma Tox"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1007\/s12325-021-01877-6","article-title":"Efficacy and safety of ciprofol sedation in ICU patients with mechanical ventilation: a clinical trial study protocol","volume":"38","author":"Liu","year":"2021","journal-title":"Adv. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/CM9.0000000000001912","article-title":"Safety and efficacy of ciprofol vs. propofol for sedation in intensive care unit patients with mechanical ventilation: a multi-center, open label, randomized, phase 2 trial","volume":"135","author":"Liu","year":"2022","journal-title":"Chin. Med. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7443226","DOI":"10.1155\/2023\/7443226","article-title":"Ciprofol: a novel alternative to propofol in clinical intravenous anesthesia?","volume":"2023","author":"Lu","year":"2023","journal-title":"BioMed Res. Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s12630-013-9991-x","article-title":"Airway management and oxygenation in obese patients","volume":"60","author":"Murphy","year":"2013","journal-title":"Can. J. Anesth\/J Can. Anesth."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.23736\/S0375-9393.24.18203-X","article-title":"Ciprofol versus propofol for adult sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis","volume":"90","author":"Ortegal","year":"2024","journal-title":"Minerva Anestesiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12871-024-02583-w","article-title":"ED50 of ciprofol combined with sufentanil for fiberoptic bronchoscopy of different patient populations with pulmonary tuberculosis","volume":"24","author":"Pan","year":"2024","journal-title":"BMC Anesthesiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1021\/acs.jmedchem.7b00254","article-title":"Design, synthesis, and evaluation of novel 2,6-disubstituted phenol derivatives as general anesthetics","volume":"60","author":"Qin","year":"2017","journal-title":"J. Med. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41569-023-00846-6","article-title":"Obstructive sleep apnoea heterogeneity and cardiovascular disease","volume":"20","author":"Redline","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1213\/00000539-199112000-00019","article-title":"Pharmacokinetics of sufentanil in obese patients","volume":"73","author":"Schwartz","year":"1991","journal-title":"Anesth. Analg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12630-017-0852-x","article-title":"Optimal propofol induction dose in morbidly obese patients: a randomized controlled trial comparing the bispectral index and lean body weight scalar","volume":"64","author":"Subramani","year":"2017","journal-title":"Can. J. Anesth\/J Can. Anesth."},{"key":"B20","doi-asserted-by":"publisher","first-page":"105904","DOI":"10.1016\/j.ejps.2021.105904","article-title":"Efficacy and safety of ciprofol for the sedation\/anesthesia in patients undergoing colonoscopy: phase IIa and IIb multi-center clinical trials","volume":"164","author":"Teng","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.gie.2011.09.006","article-title":"Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures","volume":"74","author":"Wani","year":"2011","journal-title":"Gastrointest. Endosc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.1021\/acs.jmedchem.7b01133","article-title":"Oral delivery of propofol with methoxymethylphosphonic acid as the delivery vehicle","volume":"60","author":"Wei","year":"2017","journal-title":"J. Med. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.bja.2020.11.037","article-title":"Determination of the ED95 of a single bolus dose of dexmedetomidine for adequate sedation in obese or nonobese children and adolescents","volume":"126","author":"Wu","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"B24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.23736\/S0375-9393.21.15917-6","article-title":"Gastroscopy sedation: clinical trial comparing propofol and sufentanil with or without remimazolam","volume":"88","author":"Xiao","year":"2022","journal-title":"Minerva Anestesiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lers.2022.12.001","article-title":"Endoscopy demand among county people in southeast China: a cross-sectional study","volume":"6","author":"Yan","year":"","journal-title":"Laparosc. Endosc. Robotic Surg."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e079095","DOI":"10.1136\/bmjopen-2023-079095","article-title":"Safety and efficacy of remimazolam tosilate combined with low-dose fentanyl for procedural sedation in obese patients undergoing gastroscopy: study protocol for a single-centre, double-blind, randomised controlled trial","volume":"13","author":"Yan","year":"","journal-title":"BMJ Open"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1164\/rccm.2109080","article-title":"Epidemiology of obstructive sleep apnea: a population health perspective","volume":"165","author":"Young","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2147\/DDDT.S453486","article-title":"Exploring the median effective dose of ciprofol for anesthesia induction in elderly patients: impact of frailty on ED50","volume":"18","author":"Yuan","year":"2024","journal-title":"DDDT"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1021\/acs.jmedchem.7b00253","article-title":"Design, synthesis, and evaluation of a series of novel benzocyclobutene derivatives as general anesthetics","volume":"60","author":"Zhang","year":"2017","journal-title":"J. Med. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.dld.2023.09.016","article-title":"Comparison of ciprofol\u2013alfentanil and propofol\u2013alfentanil sedation during bidirectional endoscopy: a prospective, double-blind, randomised, controlled trial","volume":"56","author":"Zhang","year":"","journal-title":"Dig. Liver Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1386129","DOI":"10.3389\/fphar.2024.1386129","article-title":"ED50 of ciprofol combined with different doses of remifentanil during upper gastrointestinal endoscopy in school-aged children: a prospective dose-finding study using an up-and-down sequential allocation method","volume":"15","author":"Zhang","year":"","journal-title":"Front. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2147\/DDDT.S408076","article-title":"Efficacy and safety of a subanesthetic dose of esketamine combined with propofol in patients with obesity undergoing painless gastroscopy: a prospective, double-blind, randomized controlled trial","volume":"17","author":"Zheng","year":"2023","journal-title":"Drug Des. Devel Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"111047","DOI":"10.1016\/j.jclinane.2022.111047","article-title":"Efficacy and safety of Ciprofol for procedural sedation and anesthesia in non-operating room settings","volume":"85","author":"Zhong","year":"2023","journal-title":"J. Clin. Anesth."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1521715\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T09:52:10Z","timestamp":1739872330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1521715\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":34,"alternative-id":["10.3389\/fphar.2025.1521715"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1521715","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"article-number":"1521715"}}